1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Optimized background ARV therapy: new trials by email Literature Review of Optimized background ARV therapy trials Research Report on Optimized background ARV therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure. enfuvirtide [Fuzeon], Optimized background ARV therapy - HIV Infections | Phase 2 | Completed | Hoffmann-La Roche | 29 | 2008-01-01 | 2015-01-27 |
HIV Infections (1)
France (1)